论文部分内容阅读
一、病例来源本文选择我院儿传病区1987～1989年住院治疗的120例小儿急性肝炎作为分析对象,全部病例均符合1984年南宁会议所制订的标准。治疗组和对照组各60例,病情轻重及肝功改变相似。年龄为1～12岁。治疗组有急性黄疸型肝炎52例、无黄疸型8例,16例HBsAg(+);对照组急性黄疸型肝炎50例,无黄疸型10例,14例HBsAg(+)。二、治疗方法治疗组以联苯双酯胶囊(1.5mg粒)口服为主,1粒/岁/次(不>10粒/次),每日/3次,连续服用。同时使用维生素B_1、C、食母生、肝太乐及中药口服,个别病例静滴葡萄糖及能量合剂
First, the source of the case This article chooses 120 cases of pediatric acute hepatitis treated as pediatric patients from 1987 to 1989 in our pediatric pediatric ward, all cases are in line with the standards set by Nanning Conference in 1984. The treatment group and the control group of 60 cases, severity and similar changes in liver function. Age is 1 to 12 years old. In the treatment group, there were 52 cases of acute jaundice hepatitis, 8 cases without jaundice and 16 cases of HBsAg (+). The control group had 50 cases of acute jaundice hepatitis, 10 cases without jaundice and 14 cases with HBsAg (+). Second, the treatment of the treatment group to diphenoxylate capsules (1.5mg tablets) mainly oral, 1 / year / times (not more than 10 capsules / time), daily / 3 times, taking continuously. At the same time the use of vitamin B_1, C, fresh mother, liver too much medicine and oral, individual cases of intravenous glucose and energy mixture